MEDICINES FOR CHILDREN

Strategic Advisory Group

The EAP Medicines for Children Strategic Advisory Group was established to advocate for equal access to safe, modern and affordable therapeutic medicine options to support diagnosis, treatment and prevention of diseases – especially for children/young persons in Europe.

Burning Issues Include:

  • The correct administration of medicine in children (appropriate formulations and the dosage).
  • The lack of medicines that are appropriate for, and specifically aimed, at children.
  •  Excessive prices of some orphan drugs for rare diseases / high expense low volume medications.
  •  The remaining large number of prescriptions of off-label drugs in our patients.
  •  Lack of Investment in drugs for specific paediatric indications/needs.
  •  Insufficient infrastructure/networks to perform multicentred paediatric trials across Europe.

SPRING MEETINGS

Coming Soon...

WINTER MEETINGS

Winter Meeting 2021

Virtual SAG meetings | 20 Jan 2022

SPRING MEETINGS

Coming Soon...

WINTER MEETINGS

Winter Meeting 2021

Virtual SAG meetings | 20 Jan 2022

Don't Wait Any Longer.
Sign up to receive our News!

EAP UEMS-SP INTERNAL FUND IN UEMS 2014-2017

Share This